Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice the first effects of Mounjaro within the first one to three days of their initial injection — typically a reduction in appetite, earlier fullness, and some degree of nausea. Measurable weight change takes longer, usually becoming noticeable over weeks rather than days. Mounjaro (tirzepatide) is a prescription-only medicine; a clinical assessment determines whether it is appropriate for you before any treatment begins. What follows is a practical guide to the timeline most people experience, drawn from the clinical evidence and the NHS tirzepatide medicines page.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the morning after your first Mounjaro injection. Your plain, unbranded box will have arrived via DPD the previous working day, and you have stored the pen in the fridge as instructed. You inject, go about your day, and then, somewhere between a few hours and a couple of days later, something shifts. Lunch arrives and you are simply not that interested in finishing it.
That early appetite dampening is Mounjaro doing exactly what it is designed to do. As a dual GIP and GLP-1 receptor agonist (the only medicine of its kind licensed in the UK for weight management) tirzepatide begins slowing gastric emptying almost immediately. Food moves through the stomach more slowly, and the gut-hormone signals that tell your brain you are full arrive earlier and more insistently. The mechanism is biological, not motivational. Many people find this the most striking early change.
Nausea is also common in this window. It tends to be mild to moderate for most, peaks in the first few days, and settles considerably within one to two weeks as the body adjusts. Loose stools, indigestion, or burping can accompany it. These are the body responding to a new input, not a sign something has gone wrong. If symptoms are severe or persistent, your prescriber needs to know, do not simply push through.
If you are wondering when you feel the effects of Mounjaro after that first injection, most people notice appetite changes within the first 24 to 72 hours, though weight on the scales is probably unchanged. Water fluctuations can mask or mimic any early shift. The first injection's job is adjustment, not transformation.
By the second or third week, the gastric side effects usually settle. Appetite suppression, on the other hand, typically deepens. Meals feel satisfying earlier, snacking becomes less automatic, and the background noise of hunger quietens for many people.
Actual weight loss in this period is real but modest at the 2.5mg starting dose. That dose exists to settle your system, not to carry the therapeutic load. Expect somewhere between one and three kilograms over the first month in a typical case, though the range varies widely and depends on diet, activity, and individual physiology. The trial data reflects averages across thousands of adults; your own early numbers may sit anywhere within that spread.
Around week four, your prescriber will review progress. If you have tolerated the starting dose well, the titration to 5mg begins. Many people report that the shift upward brings a fresh wave of mild GI symptoms for a few days, then a further step-change in appetite control. This pattern (adjustment, then deeper effect) tends to repeat at each dose increase. For a broader look at the changes Mounjaro produces throughout treatment, our Mounjaro effects overview covers the full picture.
This is the phase most people are asking about when they want to know when they will feel the effects of Mounjaro in a meaningful way. The answer, honestly, is that the meaningful weight results take time, and that is by design, not a flaw.
As the dose climbs through 5mg, 7.5mg and beyond, appetite suppression strengthens and gastric emptying slows further. Many people find their relationship with food shifts noticeably: smaller portions feel satisfying, high-calorie foods lose some of their pull, and eating past fullness feels uncomfortable rather than easy. Combined with a reduced-calorie diet and increased activity, these effects compound.
By the three-month mark, weight loss of five to ten percent of body weight is a reasonable expectation for many people, though again, individual results vary. The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults over 72 weeks, those on the highest dose saw around 20–21% average reduction. That figure is the destination, not the six-week result. Reaching a maintenance dose takes months of careful titration, reviewed at every step by your prescriber.
If you are thinking about what starting treatment involves, the practical guide to starting Mounjaro covers the consultation process and what to expect before your first pen arrives. Cost context is worth understanding too; the Mounjaro price comparison page sets out what private treatment typically includes across providers.
Some people reach a dose where appetite suppression levels off and weight loss slows, and understanding how soon you feel the effects of Mounjaro at each stage can help set realistic expectations when progress feels slower than hoped. That is not failure. Plateaus are a well-documented part of any weight-management journey, and the NICE appraisal of tirzepatide (TA1026) notes that if less than five percent weight loss has occurred after six months at the highest tolerated dose, continuing treatment should be reviewed clinically.
The right response to a plateau is a conversation with your prescriber, not a change made independently. Timing of dose increases, dietary adjustments, and activity levels all play a role, none of which should be altered without clinical input. A question our prescribers hear regularly is whether slower-than-expected early results mean the medicine is not working. Usually, the answer is that the effective dose has not yet been reached.
If you have questions about your own progress or timeline, our support team is available seven days a week. For anyone still considering whether Mounjaro is right for them, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.